Profiel
Philip A.
Pemberton is Chief Technology Officer of Arriva Pharmaceuticals, Inc. Prior to joining Arriva Pharmaceuticals in 2000, he held various positions at BioMarin Pharmaceutical, Inc., LXR Biotechnology, Inc., and Harvard Medical School.
He has 18 years of experience in research and preclinical development of protease inhibitors and recombinant proteins.
Dr. Pemberton received a PhD from the University of Cambridge.
Eerdere bekende functies van Philip A. Pemberton
Bedrijven | Functie | Einde |
---|---|---|
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Hoofd Techniek/Wetenschap/O&O | 19-01-2011 |
LXR Biotechnology, Inc.
LXR Biotechnology, Inc. BiotechnologyHealth Technology LXR Biotechnology, Inc. engages in research and development of therapeutics to treat diseases. The private company is based in Richmond, CA. The company was founded by Scott Minick. | Corporate Officer/Principal | - |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Opleiding van Philip A. Pemberton
University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
LXR Biotechnology, Inc.
LXR Biotechnology, Inc. BiotechnologyHealth Technology LXR Biotechnology, Inc. engages in research and development of therapeutics to treat diseases. The private company is based in Richmond, CA. The company was founded by Scott Minick. | Health Technology |